Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patients

Journal of Surgical Oncology

Volumn 82, Issue 2, 2003, Pages 91-97

  Motomura, Kazuyoshi ^a   Komoike, Yoshifumi ^a   Hasegawa, Yoshihisa ^a   Kasugai, Tsutomu ^a   Inaji, Hideo ^a   Noguchi, Shinzaburo ^b   Koyama, Hiroki ^a  

^a Osaka Medical Center for Cancer   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Breast cancer; Intradermal injection; Sentinel node; Sentinel node biopsy

Indexed keywords

RADIOISOTOPE; TECHNETIUM 99M;

ADULT; ARTICLE; BREAST CANCER; DIAGNOSTIC ACCURACY; HUMAN; IMAGING; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PARTICLE SIZE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE;

EID: 0037309543     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10200     Document Type: Article

References (29)

1. Fisher B, Redmond C, Fisher ER, et al.: Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with and without irradiation. N Engl J Med 1985;312:674-681.
2. Haagensen C: The surgical treatment of mammary carcinoma. In: "Disease of the Breast." 2nd ed. Philadelphia: WB Saunders, 1971. 704-709.
3. Renolleau C, Merviel P, Clough KB, et al.: Isolated axillary recurrences after conservative treatment of breast cancer. Eur J Cancer 1996;32A:617-621.
4. Hayward J: The Guy's trial of treatment of early breast cancer. World J Surg 1998;1:314-316.
5. Cabanes PA, Salmon RJ, Vilcoq JR, et al.: Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 1992;339:1245-1248.
6. Ivens D, Hoe AL, Podd TJ, et al.: Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136-138.
7. Recht A, Houlihan MJ: Axillary lymph nodes and breast cancer: A review. Cancer 1995;76:1491-1512.
8. Morrow M: Role of axillary dissection in breast cancer management. Ann Surg Oncol 1996;3:233-234.
9. Kissen MW, Querci della Rovere G, Easton D, Westbury G: Risk of lymphedema after the treatment of breast cancer. Br J Surg 1986;73:580-584.
10. Nieweg OE, Tanis PJ, Kroon BBR, et al.: The definition of a sentinel node. Ann Surg Oncol 2001;8:538-541.
11. Giuliano AE, Kirgan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
12. Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350.
13. Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-339.
14. Veronesi U, Paganelli G, Galimberti V, et al.: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-1867.
15. Albertini JJ, Lyman GH, Cox CE, et al.: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-1822.
16. Cox CE, Pendas S, Cox JM, et al.: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645-653.
17. Motomura K, Inaji H, Komoike Y, et al.: Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol 2001;76:95-99.
18. McMasters KM, Wong SL, Martin RCG, et al.: Dermal injection of radioactive colloid is superior to peritumoural injection for breast cancer sentinel lymph node biopsy: Results of a multi-institutional study. Ann Surg 2001;233:676-684.
19. Greenberg RS: "Medical Epidemiology." Norwalk, CT: Appleton & Lange, 1993.
20. Krag DN, Ashikaga T, Harlow SP, Weaver DL: Development of sentinel node targeting technique in breast cancer patients. Breast 1998;4:67-74.
21. Miner TJ, Shriver CD, Jaques DP, et al.: Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer. Ann Surg Oncol 1998;5:315-321.
22. Cody HS, Borgen PI: State-of the-art approaches to sentinel node biopsy for breast cancer: Study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol 1999;8:85-91.
23. Linehan DC, Hill ADK, Akhurst T, et al.: Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 1999;6:450-454.
24. Martin RCG, Derossis AM, Fey J, et al.: Intradermal radioisotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery 2001;130:432-438.
25. Linehan DC, Hill ADK, Tran KN, et al.: Sentinel lymph node biopsy in breast cancer: Unfiltered radioisotope is superior to filtered. J Am Coll Surg 1999;188:377-381.
26. Paganelli G, de Cicco C, Cremonesi M, et al.: Optimized sentinel node scintigraphy in breast cancer. Q J Nucl Med 1998;42:49-53.
27. Boolbol SK, Fey JV, Borgen PI, et al.: Intradermal isotope injection: A highly accurate method of lymphatic mapping in breast carcinoma. Ann Surg Oncol 2001;8:20-24.
28. Wong SL, Chao C, Edwards MJ, et al.: Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Am Surg 2001;67:522-526.
29. Bedrosian I, Reynolds C, Mick R, et al.: Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 2000;88:2540-2545.